Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Psychiatry

Sec. Psychopathology

Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1633492

Emotional Speech Markers of Psychiatric Disturbance in Huntington's Disease

Provisionally accepted
Lucie  ChenainLucie Chenain1,2,3,4,5*Audrey  FabreAudrey Fabre1,3,5,6Hadrien  TiteuxHadrien Titeux1,3,5,6,7Graça  MorgadoGraça Morgado8Katia  YoussovKatia Youssov1,3,5,6,8Chloé  ClavelChloé Clavel2Anne-Catherine  Bachoud-LéviAnne-Catherine Bachoud-Lévi1,3,5,6,8
  • 1NeuroPsychologie Interventionnelle, Département d’Etudes Cognitives,, École Normale Supérieure, Paris, France
  • 2ALMANACH, INRIA, Paris, France
  • 3NeurATRIS, Paris, France
  • 4Learning Planet Institute, Université Paris Cité, Paris, France
  • 5Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris Est Créteil, Créteil, France
  • 6AP-HP, Hôpital Henri Mondor-Albert Chenevier, Centre de référence Maladie de Huntington, Service de Neurologie, Créteil, France
  • 7Laboratoire de Sciences Cognitives et Psycholinguistique, CNRS 8554, PSL University, 29 rue d’Ulm,, Paris, France
  • 8Inserm, Centre d’Investigation Clinique 1430, AP-HP, Hôpital Henri Mondor, Créteil, France, Créteil, France

The final, formatted version of the article will be published soon.

Introduction: Psychiatric disorders and difficulties in emotional expression represent a major problem in the management of Huntington's Disease (HD). To improve patient follow-up, we propose to investigate the link between emotional expression and psychiatric symptoms, measured by the Problem Behaviors Assessment (PBA) scale. To this aim we developed the first emotional/psychiatric speech corpus, emoHD.Methods: We included 102 HD gene carriers and 35 healthy controls (HC). Psychiatric symptoms were assessed using PBA sub-scales for Depression, Irritability/aggressivity, Apathy, and Obsessive/compulsive symptoms. Speech was annotated using three emotional descriptors: primary emotions, affective phenomena, and activation levels. Affective phenomena labels were selected based on PBA statements by external participants unaware of the study's aims. We analyzed (1) emotional descriptors' relationships, (2) emotional expression differences between HD and HC, and (3) the associations between emotions and psychiatric symptoms.Results: HD patients showed reduced emotional expressiveness than HC with more neutral activation levels (=0). Only the primary emotion "angry" was less expressed in HD compared to HC. In contrast they expressed more affective phenomena states like apathetic, confused, "depressed", "disoriented", "frustrated", and "pessimistic" than HC, whereas they expressed less "other" and "irritable" than HC. Expressed emotions were congruent with psychiatric symptoms (e.g., "anxious" and "nervous" are positively associated with Depression PBA subscale; "frustrated" with Irritability/aggressivity PBA sub-scale).We showed that speech is a promising marker for emotional/psychiatric symptoms in HD, supporting future remote monitoring and personalized care strategies.

Keywords: Huntington's disease, emotional expression, psychiatric symptoms, Speech analysis, remote monitoring

Received: 22 May 2025; Accepted: 24 Jul 2025.

Copyright: © 2025 Chenain, Fabre, Titeux, Morgado, Youssov, Clavel and Bachoud-Lévi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lucie Chenain, NeuroPsychologie Interventionnelle, Département d’Etudes Cognitives,, École Normale Supérieure, Paris, France

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.